The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.

Abroad (travel likely)Recruiting

Conditions

Glioblastoma · Glioblastoma Multiforme · Glioblastoma Multiforme of Brain · Astrocytoma, Grade IV · Brain Tumor · Brain Cancer · Brain Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Hospital Ghent, Ghent, Belgium
Contact: Study coordinator (Giorgio Hallaert, MD PhD) · g.hallaert@uzgent.be · 003293326876
Elisabeth-Tweesteden Ziekenhuis, Tilburg, North Brabant, Netherlands
Contact: Study coordinator (Geert Jan Rutten, MD PhD) · g.rutten@etz.nl · +310132210000
Erasmus MC, Rotterdam, South Holland, Netherlands
Contact: Study coordinator (Arnaud Vincent, MD PhD) · a.vincent@erasmusmc.nl · +31639428949
Contact: Study coordinator (Jasper Gerritsen, MD) · j.gerritsen@erasmusmc.nl · +31629119553
Medical Center Haaglanden, The Hague, South Holland, Netherlands
Contact: Study coordinator (Marike Broekman, MD PhD) · m.broekman@haaglandenmc.nl · +31639758253
University Medical Center Groningen, Groningen, Netherlands
Contact: Study coordinator (Michiel Wagemakers, MD PhD) · m.wagemakers@umcg.nl · +310503616161

Study leads

Arnaud Vincent, MD PhD
Principal Investigator
Erasmus Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Glioblastoma · Anaplastic Astrocytoma · Anaplastic Oligoastrocytoma

Abroad (travel likely)RecruitingPHASE2

New York, United States

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Meningioma · Glioblastoma · Acoustic Neuroma

Abroad (travel likely)RecruitingEARLY_PHASE1

Nashville, United States

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Glioblastoma · Brain Tumor

Abroad (travel likely)RecruitingPHASE2

Cleveland, United States

First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

Astrocytoma · Glioblastoma · Progressive Disease

Abroad (travel likely)RecruitingPHASE1

Minneapolis, United States